Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) poses a significant healthcare challenge, accounting for nearly 6.1% of global cancer cases. Early detection, facilitated by population screening utilizing innovative biomarkers, is pivotal for mitigating CRC incidence. This study aims to scrutinize the fecal and salivary microbiomes of CRC-positive individuals (CPs) in comparison to CRC-negative counterparts (CNs) to enhance early CRC diagnosis through microbial biomarkers.
No takes yet. Share an insight, caveat, or question.
Rezasoltani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: